drug
polymyxin B
Marketedupdated 3mo agoby Xellia Pharmaceuticals USA LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE6 co-mentions · 2 sources
- drugET-8004 co-mentions · 2 sources
- tagApproval4 co-mentions · 2 sources
- drugHYDROCORTISONE4 co-mentions · 2 sources
- tagRecall2 co-mentions · 2 sources
- drugMeropenem HQ1 co-mentions · 1 sources
- drugneomycin sulfate1 co-mentions · 1 sources
- drugceftazidime1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying polymyxin B
- phase1A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy Volunteers
- phase1A Phase I Study Comparing the Safety, Pharmacokinetics and Renal Effects of VRP-034 and Marketed Polymyxin B in Healthy Volunteers
- phase2Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
- phase3Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
- phase2PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
- phase2Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that